Drug Trial Radar · NCT06605963
PPV-06 Vaccine in Inflammatory Knee Osteoarthritis
Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
204
Planned (sponsor's estimate)
Start
Apr 2027
Primary completion
Dec 2030
Study completion Dec 2030
Sponsor
- Lead sponsor
- Peptinov SASIndustry
- Sponsor type
- Industry
- First posted
- Sep 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PPV-06 targets interleukin-6, a key molecule implicated in many inflammatory diseases such osteoarthritis. PPV-06 is used to induce the production of antibodies directed against IL-6. The antibodies produced will neutralize the interleukine-6 involved in the body's inflammatory process. The goal of this clinical trial is to test the safety and efficacy of PPV-06 in participants with Knee Osteoarthritis. The main questions are to evaluate if PPV-06 can reduce pain and improve functioning in participants with knee osteoarthritis, and to evaluate if ¨PPV-06 is safe when administered to participants. Participants will be administered with 6 subcutaneous injections of either PPV-06 or placebo, over a two-year period.
Conditions
- Osteoarthritis, Knee
Interventions
PPV-06Drug
6 subcutaneous injections at Day 1, Week 4, Week 24, Week 44, Week 64, Week 84
PlaceboDrug
6 subcutaneous injections at Day 1, Week 4, Week 24, Week 44, Week 64, Week 84
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the efficacy of PPV-06 on pain in participants with knee OsteoarthritisTime frame: From Baseline to Week 54
- To evaluate the efficacy of PPV-06 on physical functioning in participants with knee OsteoarthritisTime frame: From Baseline to Week 54
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CIC Cochin
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.